Structure Therapeutics is a 'no-brainer takeout' target, says Mizuho's Jared Holz
0
0
03/06/24
Dans
Amérique du Nord / États-Unis
Jared Holz, Mizuho, joins 'Fast Money' to talk Structure Therapeutics soaring on its GLP-1 data and M&A targets in the obesity drug space.
Montre plus
0 commentaires
sort Trier par
